|
⚲
|
| Jenavalve Technology Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001377801 |
| Sale | 2010-03-01 ($25.7 M Offered, $13.5 M Sold) |
| Fund | |
| Phone | 4989552790812 |
| Address | Nymphenburger Strasse 13 Munich, D-80335 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Helmut Straubinger | |
| Olivier Litzka | |
| Michael Dormer | |
| Regina Hodits | |
| Stephan Wehselau | |
| Carl Gilhuusmoe | |
| Markus Ferrari | |
| Arnd Kaltofen |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ATP Capital LP
✚
|
0.0 | |
|
Atreca, Inc.
✚
|
0.0 | |
|
Ingalls Kerry D.
✚
|
0.0 | |
|
Atreides Special Circumstances Fund, LLC - Series P DIs
✚
|
0.0 | |
|
Ingenco Holdings, LLC
✚
|
0.0 | |
|
Ingersoll Julianna S
✚
|
0.0 | |
|
Inherent Biosciences, Inc.
✚
|
0.0 | |
|
Atreides Special Circumstances Offshore Fund SPC - Series P
✚
|
0.0 | |
|
ATR Energy LLC
✚
|
0.0 | |
|
Atomizer 205 a series of Atomizer LLC
✚
|
0.0 |